World

AstraZeneca to make diabetes drug in China

AstraZeneca plans to invest 190 million yuan ($26.7 million) in China to build a new production line to produce a diabetes drug approved for sale in the local market in 2022.

This is reported by the Shanghai "Yicai Global" business platform.